...
首页> 外文期刊>Biosensors >Antibody Biomimetic Material Made of Pyrrole for CA 15-3 and Its Application as Sensing Material in Ion-Selective Electrodes for Potentiometric Detection
【24h】

Antibody Biomimetic Material Made of Pyrrole for CA 15-3 and Its Application as Sensing Material in Ion-Selective Electrodes for Potentiometric Detection

机译:CA 15-3的吡咯抗体仿生材料及其在电位选择离子选择电极中的传感材料应用

获取原文
           

摘要

This work reports a very simple approach for creating a synthetic antibody against any protein of interest and its application in potentiometric transduction. The selected protein was Breast Cancer Antigen (CA 15-3), which is implicated in breast cancer disease and used to follow-up breast cancer patients during treatment. The new material with antibody-like properties was obtained by molecular-imprinting technology, prepared by electropolymerizing pyrrol (Py, 5.0 × 10 ?3 mol/L) around Breast Cancer Antigen (CA 15-3) (100 U/mL) on a fluorine doped tin oxide (FTO) conductive glass support. Cyclic voltammetry was employed for this purpose. All solutions were prepared in 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, of pH 6.5. The biomarker was removed from the imprinted sites by chemical action of ethanol. The biomimetic material was then included in poly vinyl chloride (PVC) plasticized membranes to act as potentiometric ionophore, having or not a lipophilic ionic additive added. The corresponding selective electrodes were evaluated by calibration curves (in buffer and in synthetic serum) and by selectivity testing. The best analytical performance was obtained by selective electrodes including the plastic antibody and no lipophilic additive. The average limits of detection were 1.07 U/mL of CA 15-3, with a linear response from 1.44 to 13.2 U/mL and a cationic slope of 44.5 mV/decade. Overall, the lipophilic additives yielded no advantage to the overall potentiometric performance. The application of the MIP-based electrodes to the analysis of spiked synthetic serum showed precise and accurate results.
机译:这项工作报告了一种非常简单的方法来创建针对任何目标蛋白质的合成抗体,并将其应用于电位转导中。选择的蛋白质是乳腺癌抗原(CA 15-3),与乳腺癌疾病有关,在治疗期间用于随访乳腺癌患者。这种具有抗体样特性的新材料是通过分子印迹技术获得的,该技术是通过将吡咯(Py,5.0×10?3 mol / L)在乳腺癌抗原(CA 15-3)(100 U / mL)周围电聚合而制备的。氟掺杂的氧化锡(FTO)导电玻璃载体。为此使用循环伏安法。所有溶液均在pH值为6.5的4-(2-羟乙基)-1-哌嗪乙烷磺酸(HEPES)缓冲液中制备。通过乙醇的化学作用将生物标志物从印迹的位置去除。然后将仿生材料包含在聚氯乙烯(PVC)增塑膜中以充当电位离子载体,添加或不添加亲脂性离子添加剂。通过校准曲线(在缓冲液和合成血清中)和选择性测试评估相应的选择性电极。通过包括塑料抗体且不含亲脂性添加剂的选择性电极可获得最佳分析性能。平均检出限为1.07 U / mL的CA 15-3,线性响应范围为1.44至13.2 U / mL,阳离子斜率为44.5 mV /十年。总体而言,亲脂性添加剂对整体电位测量性能没有优势。基于MIP的电极在加标合成血清分析中的应用显示了准确而准确的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号